Efficacy and safety of single-agent pralatrexate for treatment of angioimmunoblastic T-cell lymphoma after failure of first line therapy: a pooled analysis.

Leukemia & Lymphoma
Jun ZhuKensei Tobinai

Abstract

Angioimmunoblastic T-cell lymphoma (AITL) is a histological subtype of peripheral T-cell lymphoma associated with a poor prognosis. This post-hoc pooled analysis aims to provide insight about the efficacy of pralatrexate monotherapy in a subset of twenty-nine patients with relapsed or refractory (r/r) AITL drawn from two prospective registration trials completed in China and Japan. After a median of two prior lines of therapy, an overall response rate of 52% (15/29 patients; 95% CI 0.34, 0.70) was demonstrated. The estimated median duration of response, progression free survival (PFS) and overall survival (OS) were 6.4 months (196 days), 5.0 months (151 days), and 18.0 months (548 days), respectively. Grades 1-3 mucositis was observed in twenty-three patients (79.3%); and hemato-toxicity in twenty-six (89.7%) patients. Results of this analysis corroborate with data from two previously reported US retrospective cohorts, supporting the potential benefits of pralatrexate monotherapy in patients with r/r AITL.

References

Feb 28, 2001·Leukemia Research·J LindahlE Hellström-Lindberg
Jul 16, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie VoseUNKNOWN International T-Cell Lymphoma Project
Dec 8, 2009·British Journal of Haematology·Laurence de LevalPhilippe Gaulard
Jan 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Owen A O'ConnorSteven Horwitz
Mar 1, 2011·Blood·Richard L PiekarzSusan E Bates
Aug 8, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Massimo FedericoJulie M Vose
Mar 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michinori OguraRyuzo Ueda
Feb 18, 2015·Annals of Hematology·Yasunori KogureMineo Kurokawa
Jun 24, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Owen A O'ConnorAndrei Shustov
Jun 25, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Y ShiX Lu
Jan 25, 2017·Blood·Matthew A Lunning, Julie M Vose
Mar 17, 2017·Journal of Hematology & Oncology·Yuankai ShiYizhuo Zhang

❮ Previous
Next ❯

Citations

Jul 31, 2020·Leukemia & Lymphoma·Carrie van der WeydenHenry Miles Prince
Oct 8, 2020·Leukemia & Lymphoma·Mansi BhuraniHenry Miles Prince

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
Yuqin SongChunxiao Cai
Cancer Treatment and Research
Mariko YabeAlison J Moskowitz
© 2022 Meta ULC. All rights reserved